Dendreon Corporation
54Patents
21Active
54Granted
44Portfolio score
Filing activity: Nov 10, 1993 → Sep 5, 2014 · 14 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7012066B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Human Necessities | 83 | Expired |
| US6080409A | Immunostimulatory method | Chemistry; Metallurgy | 76 | Expired |
| US7244721B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Human Necessities | 50 | Expired |
| US6800434B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Human Necessities | 47 | Expired |
| US6416958B2 | Selective apoptosis of neoplastic cells by an HLA-DR specific monoclonal antibody | Chemistry; Metallurgy | 44 | Expired |
| US5976546A | Immunostimulatory compositions | Chemistry; Metallurgy | 27 | Expired |
| US6194152A | Prostate tumor polynucleotide compositions and methods of detection thereof | Chemistry; Metallurgy | 24 | Expired |
| US7169760B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Chemistry; Metallurgy | 24 | Expired |
| US6197579A | Cell washing device and method | Physics | 21 | Expired |
| US7414108B2 | Composition and method for producing an immune response against tumor-related antigens | Chemistry; Metallurgy | 17 | Expired |
| US6210662A | Immunostimulatory composition | Chemistry; Metallurgy | 16 | Expired |
| US5789148A | Cell separation composition | Emerging Cross-Sectional Technologies | 16 | Expired |
| USRE43298E1 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | General | 15 | Active |
| US7329640B2 | Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor | Human Necessities | 14 | Active |
| US7700341B2 | Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon | Chemistry; Metallurgy | 12 | Expired |
| US6015843A | Process for making silanized colloidal silica | Chemistry; Metallurgy | 12 | Expired |
| US7572444B2 | Binding proteins specific for human matriptase | Physics | 9 | Expired |
| US7597894B2 | Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7172892B2 | Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7112430B2 | Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6121044A | Potent antigen presenting cell composition | Chemistry; Metallurgy | 6 | Expired |
| US7019019B2 | Matriptase inhibitors and methods of use | Chemistry; Metallurgy | 4 | Expired |
| US7060279B2 | Compositions and methods for dendritic cell-based immunotherapy | Chemistry; Metallurgy | 3 | Expired |
| US5998599A | Growth arrest gene compositions and methods | Human Necessities | 3 | Expired |
| US7125703B2 | Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon | Emerging Cross-Sectional Technologies | 3 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.